Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Cardio-Thoracic Surgery

• Publication date

  2007-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.EJCTS.2006.11.057PMID 17239611
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement

  2006cited by this paper
• Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

  2006cited by this paper
• Differentiation of bone marrow mesenchymal stem cells induced by myocardial medium under hypoxic conditions

  2006cited by this paper
• The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.

  2005cited by this paper
• Stem cell therapy in the aging hearts of Fisher 344 rats: synergistic effects on myogenesis and angiogenesis.

  2005cited by this paper
• Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

  2004cited by this paper
• Insulin‐Like Growth Factor Promotes Engraftment, Differentiation, and Functional Improvement after Transfer of Embryonic Stem Cells for Myocardial Restoration

  2004cited by this paper
• Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair.

  2003cited by this paper
• Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells.

  2003cited by this paper
• Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart

  2002cited by this paper
• Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.

  2001cited by this paper
• Progression of heart failure after myocardial infarction in the rat.

  2001cited by this paper
• Bone marrow cells regenerate infarcted myocardium

  2001cited by this paper
• Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

  2001cited by this paper
• Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies.

  2001cited by this paper
• Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury.

  2001cited by this paper
• Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages.

  2000cited by this paper
• Congestive Heart Failure: Fifty Years of Progress

  2000cited by this paper
• Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.

  1999cited by this paper
• Autologous transplantation of bone marrow cells improves damaged heart function.

  1999cited by this paper
• Development of Approaches to Improve Cell Survival in Myoblast Transfer Therapy

  1998cited by this paper
• Long-term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction.

  1996cited by this paper
• Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.

  1995cited by this paper
• Brain 'ouabain' mediates sympathetic hyperactivity in congestive heart failure.

  1995cited by this paper
• Regional differences in LV collagen accumulation and mature cross-linking after myocardial infarction in rats.

  1994cited by this paper

• Extracorporeal cardiac shock wave stimulation enhances the therapeutic efficacy of intravenously delivered endothelial colony-forming cells via PI3K/AKT signaling in a rat myocardial infarction model

  2026cites this paper
• Injectable Stem Cell-Based Therapies for Myocardial Regeneration: A Review of the Literature

  2025cites this paper
• Induced Pluripotent Stem Cell-Derived Cardiomyocytes Therapy for Ischemic Heart Disease in Animal Model: A Meta-Analysis

  2024cites this paper
• Timely delivery of bone marrow mesenchymal stem cells based on the inflammatory pattern of bone injury environment to promote the repair of calvarial bone defects in rats: An optimized strategy for bone tissue engineering

  2024cites this paper
• Severely Damaged Freeze-Injured Skeletal Muscle Reveals Functional Impairment, Inadequate Repair, and Opportunity for Human Stem Cell Application

  2023cites this paper
• Recent Emerging Trend In Stem Cell Therapy Risk Factors.

  2022cites this paper
• Bone Marrow Mesenchymal Stem Cells in Acute-on-Chronic Liver Failure Grades 2 and 3: A Phase I-II Randomized Clinical Trial

  2021cites this paper
• Application of Cell, Tissue, and Biomaterial Delivery in Cardiac Regenerative Therapy.

  2021cites this paper
• Differentiation of embryonic stem cells into a putative hair cell-progenitor cells via co-culture with HEI-OC1 cells

  2021cites this paper
• Mesenchymal Stem Cells for Chronic Wound Healing: Current Status of Preclinical and Clinical Studies

  2020cites this paper
• Safety and efficacy of cell therapies in pediatric heart disease: a systematic review and meta-analysis

  2020cites this paper
• Strengthening effects of bone marrow mononuclear cells with intensive atorvastatin in acute myocardial infarction

  2020cites this paper
• Optimization of Timing and Times for Administration of Atorvastatin‐Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction

  2019cites this paper
• Mesenchymal stem cells' homing and cardiac tissue repair.

  2019cites this paper
• Exosomes derived from adipose tissue, bone marrow, and umbilical cord blood for cardioprotection after myocardial infarction

  2019cites this paper
• Encapsulation of Explant-Derived Cardiac Stem Cells in Agarose Nanoporous Gel Cocoons to Enhance Cardiac Repair

  2019cites this paper
• Mechanical Circulatory Support and Stem Cell-Based Heart Treatment in Europe-2018 Clinical Update.

  2018cites this paper
• Stem Cell Homing: a Potential Therapeutic Strategy Unproven for Treatment of Myocardial Injury

  2018cites this paper
• Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery.

  2018cites this paper
• Unmodified, autologous adipose-derived regenerative cells improve cardiac function, structure and revascularization in a porcine model of chronic myocardial infarction

  2018cites this paper
• Concise Review: Optimized Strategies for Stem Cell‐Based Therapy in Myocardial Repair: Clinical Translatability and Potential Limitation

  2018cites this paper
• Conception de vecteurs polymères pour l’imagerie moléculaire et le traitement ciblé de la thrombose

  2017cites this paper
• Depressive disorder and gastrointestinal dysfunction after myocardial infarct are associated with abnormal tryptophan-5-hydroxytryptamine metabolism in rats

  2017cites this paper
• The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis

  2017cites this paper
• Progress of Stem Cell Transplantation for Treating Myocardial Infarction.

  2017cites this paper
• Investigating scaffold designs for progenitor cells-based cell therapy for cardiac repair

  2017cites this paper
• Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction: A Meta-Analysis of Preclinical Studies and Clinical Trials

  2017cites this paper
• Cellular mechanisms underlying cardiac engraftment of stem cells

  2017cites this paper
• Optimal Environmental Stiffness for Stem Cell Mediated Ischemic Myocardium Repair.

  2017cites this paper
• Reconstruction of cranial cruciate ligament in rabbits using polyester implants saturated with PRP, antlerogenic stem cells MIC-1 and their homogenate

  2017cites this paper
• Effects of diagnostic ultrasound-targeted microbubble destruction on the homing ability of bone marrow stromal cells to the kidney parenchyma

  2016cites this paper
• Infarcted cardiac microenvironment may hinder cardiac lineage differentiation of human embryonic stem cells

  2016cites this paper
• Dynamic Tracking of Injected Mesenchymal Stem Cells after Myocardial Infarction in Rats: A Serial 7T MRI Study

  2016cites this paper
• Human Mesenchymal Stromal Cells Improve Cardiac Perfusion in an Ovine Immunocompetent Animal Model

  2016cites this paper
• Nicorandil enhances the efficacy of mesenchymal stem cell therapy in isoproterenol-induced heart failure in rats.

  2015cites this paper
• How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?

  2015cites this paper
• The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy

  2015cites this paper
• Injectable Hydrogels with In Situ Double Network Formation Enhance Retention of Transplanted Stem Cells

  2015cites this paper
• Mesenchymal Stem Cells for Cardiac Regenerative Therapy: Optimization of Cell Differentiation Strategy

  2015cites this paper
• Intracellular transduction of TAT-Hsp27 fusion protein enhancing cell survival and regeneration capacity of cardiac stem cells in acute myocardial infarction.

  2015cites this paper
• Mesenchymal stromal cells overexpressing vascular endothelial growth factor in ovine myocardial infarction

  2015cites this paper
• Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-Pigs

  2015cites this paper
• Polysaccharide-based strategies for heart tissue engineering.

  2015cites this paper
• The Role of Bioactive Lipids in Stem Cell Mobilization and Homing: Novel Therapeutics for Myocardial Ischemia

  2014cites this paper
• Cell therapy to regenerate the ischemic heart

  2014cites this paper
• Mechanisms Regulating Trafficking of Stem Cells in Ischemic Heart Disease

  2014cites this paper
• Nesprin-1 has key roles in the process of mesenchymal stem cell differentiation into cardiomyocyte-like cells in vivo and in vitro

  2014cites this paper
• Concise Review: Injectable Biomaterials for the Treatment of Myocardial Infarction and Peripheral Artery Disease: Translational Challenges and Progress

  2014cites this paper
• Interaction between myofibroblasts and stem cells in the fibrotic heart: balancing between deterioration and regeneration.

  2014cites this paper
• Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury.

  2014cites this paper
• Mesenchymal Stem Cells and Their Conditioned Medium Improve Integration of Purified Induced Pluripotent Stem Cell–Derived Cardiomyocyte Clusters into Myocardial Tissue

  2014cites this paper
• Allogeneic adipose stem cell therapy in acute myocardial infarction

  2014cites this paper
• Differential regeneration of myocardial infarction depending on the progression of disease and the composition of biomimetic hydrogel.

  2014cites this paper
• Cobalt Protoporphyrin Pretreatment Protects Human Embryonic Stem Cell‐Derived Cardiomyocytes From Hypoxia/Reoxygenation Injury In Vitro and Increases Graft Size and Vascularization In Vivo

  2014cites this paper
• Adult Stem Cell Therapies: Alternatives to Plasticity

  2014cites this paper
• Cardiac Stem Cells: Biology and Therapeutic Applications

  2013cites this paper
• Ovine amniotic epithelial cells: in vitro characterization and transplantation into equine superficial digital flexor tendon spontaneous defects.

  2013cites this paper
• Effect of transplantation with autologous bone marrow stem cells on acute myocardial infarction.

  2013cites this paper
• Human mesenchymal stem cells: From immunophenotyping by flow cytometry to clinical applications

  2013cites this paper
• Ultrasound targeted microbubble destruction promotes angiogenesis and heart function by inducing myocardial microenvironment change.

  2013cites this paper
• Biomaterial-Stem Cell Approaches to Augment Regeneration

  2013cites this paper
• Induced Pluripotent Stem Cell-Derived Cardiac Progenitors Differentiate to Cardiomyocytes and Form Biosynthetic Tissues

  2013cites this paper
• Atherosclerotic Coronary Artery Disease

  2013cites this paper
• Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction.

  2013cites this paper
• Cardiac Stem Cell Therapy: Stemness or Commitment?

  2013cites this paper
• Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation

  2013cites this paper
• MSCs for Cardiac Repair

  2013cites this paper
• Bone marrow stromal cell transplantation combined with angiotensin-converting enzyme inhibitor treatment in rat with acute myocardial infarction and the role of insulin-like growth factor-1.

  2012cites this paper
• Effects of hepatocyte growth factor overexpressed bone marrow‐derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts

  2012influential citation
• Adipose-Derived Stromal Cell Therapy Improves Cardiac Function after Coronary Occlusion in Rats

  2012cites this paper
• Cell fusion contributes to the rescue of apoptotic cardiomyocytes by bone marrow cells

  2012cites this paper
• Cardiac effects of experimental intravenous bone marrow cell transplantation after myocardial infarction.

  2012cites this paper
• Effects of bone marrow mesenchymal stem cells in a rat model of myocardial infarction.

  2012cites this paper
• The role of bone marrow derived cells in cardiac repair

  2012cites this paper
• A comprehensive study of adult stromal cells derived from mesenchymal tissues and their application in tendon regeneration

  2012cites this paper
• Conditioning of Mesenchymal Stem Cells Initiates Cardiogenic Differentiation and Increases Function in Infarcted Hearts

  2012cites this paper
• Cell Therapies for Heart Function Recovery: Focus on Myocardial Tissue Engineering and Nanotechnologies

  2012cites this paper
• Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia

  2012cites this paper
• Infarcted myocardium-like stiffness contributes to endothelial progenitor lineage commitment of bone marrow mononuclear cells

  2011cites this paper
• Mesenchymal Stem Cells for Cardiovascular Regeneration

  2011cites this paper
• Cellular cardiomyoplasty: Evidence of cellular therapy, mechanisms and controversies

  2011cites this paper
• Anti-inflammatory and immunomodulatory activities of stem cells.

  2011cites this paper
• Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses.

  2011cites this paper
• Strategies for Tissue Engineering Cardiac Constructs to Affect Functional Repair Following Myocardial Infarction

  2011cites this paper
• Experimental study of enhanced therapeutic effect of combining mesenchymal stem cell transplantation with erythropoietin in a myocardial infarction model

  2011cites this paper
• Human cardiomyogenesis and the need for systems biology analysis

  2011cites this paper
• Chapter 19 – Cardiac Stem Cells: Biology and Therapeutic Applications

  2011cites this paper
• The future of regenerating the myocardium

  2010cites this paper
• Timing of Bone Marrow Cell Delivery Has Minimal Effects on Cell Viability and Cardiac Recovery After Myocardial Infarction

  2010cites this paper
• Mid-term effect of stem cells combined with transmyocardial degradable stent on swine model of acute myocardial infarction

  2010cites this paper
• Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats.

  2010cites this paper
• Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon.

  2010cites this paper
• Stem Cell Therapy for Myocardial Infarction: Are We Missing Time?

  2010cites this paper
• Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic results.

  2010cites this paper
• Assessment and Optimization of Cell Engraftment After Transplantation Into the Heart

  2010cites this paper
• Prolyl hydroxylase inhibitor dimethyloxalylglycine enhances mesenchymal stem cell survival

  2009cites this paper
• Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.

  2009cites this paper
• Methodology, biology and clinical applications of mesenchymal stem cells.

  2009cites this paper
• Cell Therapy Attenuates Cardiac Dysfunction Post Myocardial Infarction: Effect of Timing, Routes of Injection and a Fibrin Scaffold

  2009cites this paper
• A role of myocardial stiffness in cell-based cardiac repair: a hypothesis

  2009cites this paper